Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00885706 as Add-On to Esomeprazole in GERD
NCT00730665Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jan 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of PF-00885706 in gastroesophageal reflux disease (GERD), sponsored by Pfizer. Started Jan 2008; status: terminated.
02
Drugs
PF-00885706
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00730665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730665.